Rigel Pharmaceuticals Inc (RIGL)
Net Income Growth
-71.00%
Quarterly · Period ending:
RIGL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-71.00%period ending
Latest reported-71.00%period ending
RIGL Quarterly Net Income YoY % (36.30% → -71.00%)
Year-over-year change
High-resolution chart · PNG
RIGL net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -70.9963% | |
| -24.3928% | |
| 1,769.2211% | |
| 124.6196% | |
| 5,887.6699% | |
| 238.7899% | |
| 1,845.8616% | |
| 318.2186% | |
| 84.3939% | |
| 39.0736% | |
| -47.3947% | |
| 70.1003% | |
| 51.0821% | |
| 50.6795% | |
| 106.1879% | |
| 9.1399% | |
| 2.3804% | |
| -169.481% | |
| -17.6951% | |
| -47.82% | |
| 21.3644% | |
| 85.9436% | |
| -11.843% | |
| -23.3594% | |
| 14.7045% | |
| 220.7126% | |
| -632.8377% | |
| 51.6536% | |
| 19.3724% | |
| 27.8327% | |
| 112.4773% | |
| -34.5753% | |
| -33.4778% | |
| -59.2334% | |
| -65.9461% | |
| 21.9585% | |
| -41.4838% | |
| 12.311% | |
| -22.8817% | |
| -239.1637% | |
| 2.7243% | |
| 4.007% | |
| 43.0361% | |
| 68.1406% | |
| 45.2089% | |
| 18.428% | |
| -32.0918% | |
| 12.097% | |
| -11.5206% | |
| 12.7903% | |
| 33.8057% | |
| 6.4111% | |
| 7.9635% | |
| -10.3564% | |
| 1.2215% | |
| -41.9664% | |
| -15.1998% | |
| -11.5153% | |
| -49.5852% | |
| -135.5541% | |
| -179.448% | |
| 6.9494% | |
| 31.2996% | |
| 289.2349% | |
| 190.4555% | |
| 25.3626% | |
| 24.7902% | |
| 29.2908% | |
| 12.1896% | |
| -9.7572% | |
| -75.5815% | |
| -98.9601% | |
| -76.82% | |
| -59.6042% | |
| -22.9425% | |
| -66.4382% | |
| -725.9657% | |
| -101.6885% | |
| -73.7996% | |
| 11.8085% | |
| 81.0461% | |
| 24.1401% | |
| 39.6102% | |
| 20.0174% | |
| 0.397% | |
| 14.4587% | |
| -24.1443% | |
| -45.7765% | |
| -17.9247% | |
| -67.3205% | |
| -46.9888% | |
| -9.1402% | |
| -0.1915% | |
| 6.8323% | |
| -32.0569% | |
| -63.0809% | |
| -42.8025% | |
| -101.25% | |
| -5.965% | |
| 4.7772% |